mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.3 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.3 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.3 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.3 |
mRNA |
Pazopanib |
FIMM |
pan-cancer |
AAC |
-0.18 |
0.3 |